Safety, tolerability and efficacy of a novel self-use biodegradable device for management of obesity.
H ShirinV RichterShay MatalonD AbramowichA MaliarE ShacharS F MossE BroidePublished in: Obesity science & practice (2019)
Twelve weeks of Epitomee capsules treatment combined with lifestyle counselling resulted in 3.68-4.52% of TBWL. With continued research, the Epitomee capsules have considerable potential to become a non-invasive, safe and effective treatment option for weight loss.